Hydromorphone Hydrochloride Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Hydromorphone Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Oct 31, 2017.

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-1312-30
Dosage Form
Injection
Presentation
Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30)
Initial Posting
Oct 31, 2017

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.